Latest news & articles

Latest news

Advocacy Spotlight: Meet Joanne & Dougal

Advocacy Spotlight: Meet Joanne & Dougal

Dougal has been living with type 1 diabetes (T1D) since the age of 4, a journey that began when he complained of sore legs. Despite the absence of any family history of T1D, Joanne (Jo), a health professional and parent, quickly recognised the signs, drawing on her expertise and a colleague’s experience as a T1D […]

Community Spotlight: Meet Cara & Mya

Community Spotlight: Meet Cara & Mya

We recently sat down with an incredible mother, Cara, who has experienced the profound journey of caring for her young daughter Mya, with type 1 diabetes (T1D). Cara shares her diagnosis story, offers valuable insights into managing T1D day-to-day, and explains why she signed up for One Walk to fundraise for JDRF. Her hope for […]

Changes to the Federal Government’s Insulin Pump Program

Changes to the Federal Government’s Insulin Pump Program

The Australian Government’s Insulin Pump Program (IPP), administered by JDRF Australia, provides insulin pumps to young Australians up to the age of 21, living with type 1 diabetes (T1D), who meet certain financial and clinical eligibility requirements. The program supplies fully subsidised insulin pumps to people who would otherwise be unable to access insulin pump […]

Airport security and type 1 diabetes technology

Airport security and type 1 diabetes technology

JDRF Australia has received an update from the Department of Home Affairs (DHA) regarding the guidelines for type 1 diabetes (T1D) technology and airport security and screening. This follows ongoing issues faced by community members when travelling through airport security with insulin pumps and continuous glucose monitors (CGMs). Advice varies for each specific device, but […]

JDRF Australia announces changes to the Board

JDRF Australia announces changes to the Board

JDRF Australia, the leading organisation for type 1 diabetes (T1D) research, advocacy, and community support, is pleased to announce three additions to its Board of Directors, while at the same time farewelling two long-serving and highly valued current Directors. With a wealth of experience in the not-for-profit, insurance and investment management sectors, the three new […]

JDRF Australia and DrimTel announce new partnership

JDRF Australia and DrimTel announce new partnership

JDRF Australia and newly launched telco provider, DrimTel, have announced they are partnering in a move that will support type 1 diabetes (T1D) research breakthroughs while providing the community with technological solutions. DrimTel, which offers Mobile SIM Only, Data Only, and nbn® Plans for residential and business customers, was founded by Ljupco (Lj) Taneski after […]

Fiasp insulin to remain on the Pharmaceutical Benefits Scheme

Fiasp insulin to remain on the Pharmaceutical Benefits Scheme

MEDIA RELEASE Fiasp insulin to remain on the Pharmaceutical Benefits Scheme The new listing of Fiasp® Penfill® on the Pharmaceutical Benefits Scheme will keep the life-saving medication available to the 15,000+ Australians who rely on it Sydney, 18 September 2023: JDRF Australia is welcoming an announcement from Minister for Health, Hon Mark Butler, that Fiasp […]

Review of NDSS subsidised products: community submissions open

Review of NDSS subsidised products: community submissions open

Review of NDSS subsidised products: community submissions open The Department of Health and Aged Care (The Department) has today announced it is planning to refresh the range of products subsidised under the National Diabetes services Scheme (NDSS), to ensure the products offered continue to meet the needs of people with diabetes. This process could lead […]

JDRF advocate Shanna McGrath receives Mark Butler Local Legend Award

JDRF advocate Shanna McGrath receives Mark Butler Local Legend Award

Each year during National Volunteers Week, the Minister for Health, Hon Mark Butler, announces the winners of the Mark Butler MP Volunteer Awards. These awards recognise the local volunteers in his electorate, Hindmarsh, who are dedicated to improving the needs of the community organisations they represent. JDRF advocate, Shanna McGrath, was diagnosed with T1D when […]

Our 2023 Volunteer of the Year winners

Our 2023 Volunteer of the Year winners

It’s National Volunteer Week and this year’s theme is ‘change makers’. At JDRF, we know that no change for type 1 diabetes (T1D) has happened without the dedication of volunteers across the community. We are an organisation who was founded by volunteers and is still powered by them, including (but not limited to!) our amazing […]

Dr Ki Wook Kim awarded JDRF Career Development Award to improve type 1 diabetes risk prediction

Dr Ki Wook Kim awarded JDRF Career Development Award to improve type 1 diabetes risk prediction

Dr Ki Wook Kim, a prominent Australian researcher and emerging leader in type 1 diabetes (T1D) research based at the UNSW Sydney, has been awarded a JDRF Career Development Award (CDA) with US $1M funding committed over the next five years. Dr Kim is one of only 13 Australians to ever receive the JDRF Career […]

Insulin Pump Program extended to 21 years of age

Insulin Pump Program extended to 21 years of age

The Federal Government’s Insulin Pump Program (IPP), administered by JDRF, operates to ensure children and young adults with type 1 diabetes (T1D) who do not have the means to access a pump, have a pathway to be able to use the life-changing management technology. The IPP was established in 2008 and initially provided insulin pumps […]

Drug Verapamil shown to slow T1D progression in newly diagnosed

Drug Verapamil shown to slow T1D progression in newly diagnosed

A new study has shown drug Verapamil, regularly used to treat blood pressure, can slow type 1 diabetes progression in newly diagnosed children and teens. As researchers work to cure type 1 diabetes (T1D), the ultimate goal is to prevent the destruction of beta cells that produce insulin. A new JDRF-funded clinical trial reveals a […]

$12M invested to progress landmark ENDIA study

$12M invested to progress landmark ENDIA study

MEDIA RELEASE Australia leading type 1 diabetes research with $12M invested to progress landmark study The funding will support the extension of ENDIA, a world-first study seeking to understand the role of environmental triggers from as early as pregnancy for the onset of type 1 diabetes (T1D). 4 April 2023: JDRF Australia and funding partner […]

From Boothby to Biden: Ethan Greenfield’s journey living with type 1 diabetes and JDRF advocacy

From Boothby to Biden: Ethan Greenfield’s journey living with type 1 diabetes and JDRF advocacy

Ethan Greenfield has been living with type 1 diabetes (T1D) for seven years, after being diagnosed at just four years old. Since then, Ethan, mum Kylie, and the Greenfield family have been fiercely advocating for the T1D community on behalf of JDRF, helping key decision makers like their local Boothby Member Louise Miller-Frost and Minister […]

JDRF welcomes decision to extend availability of Fiasp on the PBS

JDRF welcomes decision to extend availability of Fiasp on the PBS

MEDIA RELEASE JDRF Australia welcomes Government’s decision to extend availability of Fiasp insulin on the Pharmaceutical Benefits Scheme The move will keep the life-saving medication in the hands of the 15,000+ people who rely on it for a further six months Sydney, 17 March 2023: JDRF Australia is today welcoming an announcement by the Albanese […]

Scheduled removal of Fiasp from the Pharmaceutical Benefits Scheme

Scheduled removal of Fiasp from the Pharmaceutical Benefits Scheme

JDRF Australia are aware that Fiasp insulin is currently scheduled for removal from the Pharmaceutical Benefits Scheme from 1 April 2023. If removed at this date, it will no longer be available at a subsidised cost however will reportedly be available privately for a period of time. This is a significant concern to us and for many […]

Meet world leading immunologist, Professor Ranjeny Thomas

Meet world leading immunologist, Professor Ranjeny Thomas

Professor Ranjeny Thomas is a world leading immunologist aiming to retrain the immune system not to attack its insulin producing cells in people with type 1 diabetes